Pharmacokinetics of cefpimizole in normal humans after single- and multiple-dose intravenous infusions
- 1 December 1984
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 26 (6) , 802-806
- https://doi.org/10.1128/aac.26.6.802
Abstract
The pharmacokinetics of cefpimizole (free acid equivalents of cefpimizole sodium), a broad-spectrum cephalosporin antibiotic, were determined after single- and multiple-dose 20-min intravenous infusions of 1, 2, and 4 g. The kinetics of single-dose administration of cefpimizole correspond to a two-compartment model with an average apparent volume of distribution of 20.0 +/- 3.5 liters, a distribution rate constant of 2.24 +/- 1.00 h-1, and a terminal rate constant of 0.358 +/- 0.036 h-1 (half-life, 1.9 h). The total body clearance was 118.6 +/- 20.2 ml/min. The primary route of elimination for cefpimizole was the renal route, with approximately 80% of the administered dose excreted as the parent compound. The elimination rate constant, as calculated from urinary excretion data, was 0.339 +/- 0.043 h-1, which is in close agreement with the terminal rate constant for plasma. Renal clearance of cefpimizole was 96.2 +/- 17.3 ml/min. Dose proportionality over the three dose levels was obtained from area under the plasma curve and cumulative urinary excretion data. The results of the multiple-dose study indicated that no apparent change in the distribution or elimination kinetics of cefpimizole occurred after the administration of 1-, 2-, and 4-g doses for 7 days, three times a day. The kinetics from the multiple-dose study were in close agreement with those from the single-dose study. No accumulation of cefpimizole occurred, and nondetectable levels was observed 24 h after administration of the last dose. Peaks that could be attributed to metabolites of cefpimizole were not observed during high-pressure liquid chromatographic analysis of either plasma or urine specimens.This publication has 18 references indexed in Scilit:
- In vitro activity and beta-lactamase stability of U-63196E, a novel cephalosporinAntimicrobial Agents and Chemotherapy, 1983
- Effects of AC-1370, a new semisynthetic cephalosporin, on phagocyte functionsAntimicrobial Agents and Chemotherapy, 1983
- Pharmacokinetics of multiple doses of ceftizoxime and their influence on fecal floraEuropean Journal of Clinical Microbiology & Infectious Diseases, 1983
- Pharmacokinetics, protein binding, and extravascular distribution of ceftizoxime in normal subjectsAntimicrobial Agents and Chemotherapy, 1982
- Pharmacokinetic characteristics of intravenous ceftriaxone in normal adultsAntimicrobial Agents and Chemotherapy, 1982
- The Pharmacokinetics of Cefotaxime and Its Metabolites in Subjects with Normal and Impaired Renal FunctionClinical Infectious Diseases, 1982
- Single- and multiple-dose pharmacokinetics of moxalactam in normal subjectsAntimicrobial Agents and Chemotherapy, 1982
- CEFTAZIDIME—A NEW EXTENDED-SPECTRUM CEPHALOSPORINThe Lancet, 1982
- Pharmacokinetics of ceftriaxone in humansAntimicrobial Agents and Chemotherapy, 1981
- Pharmacokinetics of moxalactam in subjects with normal and impaired renal functionAntimicrobial Agents and Chemotherapy, 1981